title: Acute tumor lysis syndrome after rituximab administration in Burkitt's lymphoma.
authors.forename: Zaher K
authors.initials: ZK
authors.lastname: Otrock
authors.forename: Hassan A
authors.initials: HA
authors.lastname: Hatoum
authors.forename: Ziad M
authors.initials: ZM
authors.lastname: Salem
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D000069283:Rituximab; D015275:Tumor Lysis Syndrome / Q000188:drug therapy / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab